Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?

Marinoni, Ilaria (2022). Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation? Gut, 71(5), pp. 847-848. BMJ Publishing Group 10.1136/gutjnl-2021-324664

[img]
Preview
Text
Publikation_mar.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (198kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Marinoni, Ilaria

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

0017-5749

Publisher:

BMJ Publishing Group

Language:

English

Submitter:

Cornelia Mileto

Date Deposited:

21 Dec 2021 10:26

Last Modified:

11 Apr 2022 00:12

Publisher DOI:

10.1136/gutjnl-2021-324664

PubMed ID:

33975869

Uncontrolled Keywords:

neuroendocrine cells neuroendocrine tumors pancreatic endocrine tumour pancreatic islet cell

BORIS DOI:

10.48350/162069

URI:

https://boris.unibe.ch/id/eprint/162069

Actions (login required)

Edit item Edit item
Provide Feedback